Clinical Trial Update: Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study

View source ↗

Summary

The V-GOOD study evaluated the effectiveness and tolerability of trimetazidine 80 mg once daily in patients with chronic coronary syndrome and stable angina; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Stable Angina

Drugs mentioned

• Trimetazidine (trimetazidine)

Snippet

Sponsor: Ministry of Health, Brazil | Conditions: Chronic Coronary Syndrome, Stable Angina | Status: COMPLETED